Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis — PTH  

Prosthesis Loosening Clinical Trial

Official title: Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis Double-blind Randomized Study Versus Placebo

Status Terminated

Clinical Trial Summary

This is an experimental study, prospective, comparative. This clinical trial is randomized and double-blind, Residronate versus placebo.

The study aims to demonstrate the effectiveness of risedronate in pain management, after 18 month of traitment, in patients undergoing aseptic joint prosthesis loosening. 2 groups were compared with a 1: 1 ratio. The first group receives active drug (risedronate 75mg) and the second a placebo.

Patients are treated during 18 months: 1 tablet residronate/placebo per os two consecutive days each month.

Evaluations are planned evry 6 months.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Prosthesis Failure
• Prosthesis Loosening

• NCT number: NCT02744482
• Study type: Interventional
• Source: University Hospital, Limoges
• Status: Terminated
• Phase: Phase 3
• Start date: May 2016
• Completion date: March 22, 2018